Invasive Pneumococcal Disease a Decade after Pneumococcal Conjugate Vaccine Use in an American Indian Population at High Risk for Disease | Zendy

Robert Weatherholtz | Zendy; Eugene V. Millar | Zendy; Lawrence H. Moulton | Zendy; Raymond Reid | Zendy; Karen Rudolph | Zendy; Mathuram Santosham | Zendy; Katherine L. O’Brien | Zendy

Open Access

Invasive Pneumococcal Disease a Decade after Pneumococcal Conjugate Vaccine Use in an American Indian Population at High Risk for Disease

Author(s) -

Robert Weatherholtz,

Eugene V. Millar,

Lawrence H. Moulton,

Raymond Reid,

Karen Rudolph,

Mathuram Santosham,

Katherine L. O’Brien

Publication year - 2010

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/651680

Subject(s) - medicine , pneumococcal conjugate vaccine , serotype , population , streptococcus pneumoniae , confidence interval , pneumococcal vaccine , pediatrics , conjugate vaccine , pneumococcal infections , vaccination , immunology , immunization , environmental health , biology , antibody , microbiology and biotechnology , antibiotics

Before 7-valent pneumococcal conjugate vaccine (PCV7) introduction, invasive pneumococcal disease (IPD) rates among Navajo were several-fold those of the general US population. Only 50% of IPD cases in children involved PCV7 serotypes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research